Top View
- (Aceis) and Angiotensin II Receptor Antagonists (Arbs), and Combinations Step Therapy Criteria
- Delmuno 2.5 Mg/2.5 Mg Prolonged Release Tablets Delmuno 5 Mg/5 Mg Prolonged Release Tablets
- Medicines for Cardiovascular Disease; (5Dec2017edition)(AIHW)
- COMPARING TWO KINDS of BLOOD PRESSURE PILLS: Aceis and Arbs a Guide for Adults Fast Facts
- Antihypertensive Efficacy of Telmisartan Vs Ramipril Over the 24-H
- Angiotensin Converting Enzyme (Ace) Inhibitors
- Long-Term Effects of Ramipril and Nitrendipine on Albuminuria in Hypertensive Patients with Type II Diabetes and Impaired Renal Function
- Maintenance of Blood-Pressure-Lowering Effect Following a Missed Dose of Aliskiren, Irbesartan Or Ramipril: Results of a Randomized, Double-Blind Study
- Pharmaceutical Benefits Scheme Codes
- Guidelines for ATC Classification and DDD Assignment 2011
- Download Leaflet View the Patient Leaflet in PDF Format
- APC/DTC Briefing Document ACE Inhibitors and Angiotensin II
- When Will the ACE-Inhibitors Be Declared Obsolete?
- ACE Inhibitors and Renin Inhibitors Therapeutic Class Review (TCR) August 28, 2013 the Literature Review Is Current Through January 24, 2020
- Assessment of Single Versus Twice Daily Dosing of Ramipril by Ambulatory Blood Pressure Monitoring in Patients Similar to Those Included in the HOPE Study
- Efficacy and Safety of Aliskiren, a Direct Renin Inhibitor, Compared with Ramipril in Asian Patients with Mild to Moderate Hyper
- Renin Inhibitors and Combination Products
- ALTACE Tablets (Ramipril) Are Supplied As Tablets for Oral Administration Containing 1.25 Mg, 2.5 Mg, 5 Mg and 10 Mg of Ramipril
- ALTACE (Ramipril) Capsules, Oral Capsule: 1.25 Mg, 2.5 Mg, 5 Mg, 10 Mg (3)
- Decision on Future Reimbursement Status for Medicinal Products in ATC Group
- Angiotensin Modulators: Angiotensin II Receptor Blockers Review 01/07/2011
- Redalyc.Renin Inhibitors As Antihypertensive Agents